Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 606

BillFederalSenateIn Committee
To require the Food and Drug Administration to revoke the approval of one opioid pain medication for each new opioid pain medication approved.
About This Bill
Committee
Latest Action · March 1, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congress
118th (2023–2025)
Introduced
March 1, 2023
Cosponsors (1)
0D 1R
View PDF ↗

Summary

Highlight any text to annotate
Protecting Americans from Dangerous Opioids Act This bill requires the Food and Drug Administration (FDA) to revoke approval for an opioid drug for every new opioid drug approved. (Opioids are drugs with effects similar to opium, such as certain pain medications.) In determining the drug for which to revoke approval, the FDA must prioritize revoking approval for drugs that are not abuse deterrent and consider the public health impact of drugs on the market.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.